"10.1371_journal.pone.0012815","plos one","2010-09-17T00:00:00Z","Kate A Halton; David Cook; David L Paterson; Nasia Safdar; Nicholas Graves","The Centre for Healthcare Related Infection Surveillance and Prevention, Brisbane, Queensland, Australia; Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia; Intensive Care Unit, Princess Alexandra Hospital, Brisbane, Queensland, Australia; University of Queensland Centre for Clinical Research, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia; Section of Infectious Diseases, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America","Conceived and designed the experiments: KAH DC DLP NG. Performed the experiments: KAH. Analyzed the data: KAH. Contributed reagents/materials/analysis tools: KAH DC NG. Wrote the paper: KAH DLP NS NG.","DP has held a research grant from AstraZeneca, and consulted to Three Rivers Pharmaceuticals, Leo Pharmaceuticals, AstraZeneca, Pfizer, Sanofi-Aventis and Merck. NG has received honorarium paid to attend a meeting organized by Baxter International Inc, expenses paid to present at the Interscience Conference on Antimicrobial Agents and Chemotherapy and the Society for Healthcare Epidemiology of America meetings, and advance payment for a textbook by Springer Scientific. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2010","09","Kate A Halton","KAH",5,TRUE,4,1,1,4,TRUE,TRUE,FALSE,0,NA,FALSE
